Back to ARWR
INDEPENDENT FINANCIAL GROUP, LLC → ARWR
INDEPENDENT FINANCIAL GROUP, LLC ARWR Position History
Arrowhead Pharmaceuticals, Inc. • Healthcare
Quarters held
22
Latest value
$750K
Q3 2026
Peak value
$1.2M
First seen
Q2 2021
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2021 | $258K |
| Q3 2021 | $295K |
| Q4 2021 | $353K |
| Q1 2022 | $272K |
| Q2 2022 | $240K |
| Q3 2022 | $216K |
| Q4 2022 | $241K |
| Q2 2023 | $260K |
| Q3 2023 | $202K |
| Q4 2023 | $276K |
| Q1 2024 | $239K |
| Q2 2024 | $285K |
| Q3 2024 | $426K |
| Q4 2024 | $718K |
| Q1 2025 | $507K |
| Q2 2025 | $537K |
| Q3 2025 | $584K |
| Q4 2025 | $1.1M |
| Q1 2026 | $886K |
| Q1 2026 | $964K |
| Q2 2026 | $1.2M |
| Q3 2026 | $750K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $750K | 11.5K | — | — |
| Q2 2026 | $1.2M | 14.4K | — | — |
| Q1 2026 | $964K | 15.4K | — | — |
| Q1 2026 | $886K | 14.1K | — | — |
| Q4 2025 | $1.1M | 16.1K | — | — |
| Q3 2025 | $584K | 16.9K | — | — |
| Q2 2025 | $537K | 34.0K | — | — |
| Q1 2025 | $507K | 39.8K | — | — |
| Q4 2024 | $718K | 38.2K | — | — |
| Q3 2024 | $426K | 22.0K | — | — |
| Q2 2024 | $285K | 10.9K | — | — |
| Q1 2024 | $239K | 8.3K | — | — |
| Q4 2023 | $276K | 9.0K | — | — |
| Q3 2023 | $202K | 7.5K | — | — |
| Q2 2023 | $260K | 7.3K | — | — |
| Q4 2022 | $241K | 6.0K | — | — |
| Q3 2022 | $216K | 6.5K | — | — |
| Q2 2022 | $240K | 6.8K | — | — |
| Q1 2022 | $272K | 5.9K | — | — |
| Q4 2021 | $353K | 5.3K | — | — |
| Q3 2021 | $295K | 4.7K | — | — |
| Q2 2021 | $258K | 3.1K | — | — |
Other funds holding ARWR
$464.2M
$464.2M
$407.3M
$259.8M
$108.9M
$80.5M